These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19026757)

  • 41. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.
    Rottenkolber M; Fischer R; Ibáñez L; Fortuny J; Reynolds R; Amelio J; Gerlach R; Tauscher M; Thürmann P; Hasford J; Schmiedl S
    BMC Pulm Med; 2015 May; 15():55. PubMed ID: 25943421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma.
    Mayers I ; Damant R
    Issues Emerg Health Technol; 2005 Jun; (68):1-4. PubMed ID: 15966131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.
    Decramer M; Ferguson G
    COPD; 2006 Aug; 3(3):163-71. PubMed ID: 17240618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
    Rodrigo GJ; Castro-Rodríguez JA
    Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review.
    Iftikhar IH; Imtiaz M; Brett AS; Amrol DJ
    Lung; 2014 Feb; 192(1):47-54. PubMed ID: 24153452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-acting beta2-agonists in asthma: not so SMART?
    Currie GP; Lee DK; Lipworth BJ
    Drug Saf; 2006; 29(8):647-56. PubMed ID: 16872239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regular treatment with formoterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ
    Cochrane Database Syst Rev; 2012 Apr; 4(4):CD006923. PubMed ID: 22513944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.
    Wang MT; Skrepnek GH; Armstrong E; Sherrill DL; Harris RB; Tsai CL; Malone DC
    Curr Med Res Opin; 2008 Mar; 24(3):859-67. PubMed ID: 18267052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salmeterol use and risk of hospitalization among emergency department patients with acute asthma.
    Liao MM; Ginde AA; Clark S; Camargo CA
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):478-84. PubMed ID: 20568379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
    Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Shah L; Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD007695. PubMed ID: 22419326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.